Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 84-90

  Smeets, Tom J M ^a   Dolhain, Radboud J E M ^a   Miltenburg, André M M ^a   De Kuiper, Ronella ^a   Breedveld, Ferdinand C ^a   Tak, Paul P ^a  

^a NONE

Author keywords

Cytokines; Early rheumatoid arthritis; Immunohistochemistry; T cells

Indexed keywords

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

EID: 0031830389     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4525     Document Type: Article

References (49)

1. Van Zeben D., Hazes J. M., Zwinderman A. H., Cats A., Schreuder G. M., D'Amaro J., Breedveld F. C. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Arthritis Rheum. 34:1991;822-830.
2. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56:1994;389-466.
3. Klareskog L., Holmdahl R., Larsson E., Wigzell H. Role of T lymphocytes in collagen 2 induced arthritis in rats. Clin. Exp. Immunol. 51:1983;117-125.
4. Taurog J. D., Sandberg G. P., Mahowald M. L. The cellular basis of adjuvant arthritis: characterization of the cells mediating passive transfer. Cell. Immunol. 80:1983;198-204.
5. Klareskog L., Forsum U., Scheynius A., Kabelitz D., Wigzell H. Evidence in support of a self-perpetuating HLA-DR dependent delayed type cell reaction in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 79:1982;3632-3636.
6. Pitzalis C., Kingsley G. H., Murphy J., Panayi G. S. Abnormal distribution of the helper-inducer and suppressor-inducer T lymphocyte subsets in the rheumatoid joint. Clin. Immunol. Immunopathol. 45:1987;252-258.
7. Tak P. P., Hintzen R. Q., Teunissen J. J. M., Smeets T. J. M., Daha M. R., van Lier R. A. W., Kluin P. M., Meinders A. E., Swaak A. J. G., Breedveld F. C. Expression of the activation antigen CD27 in rheumatoid arthritis. Clin. Immunol. Immunopathol. 80:1996;129-138.
8. Panayi G. S., Choy E. H. S., Connoly D. J. A., Regan T., Manna V. K., Rapson N., Kingsley G. H., Johnston J. M. T cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (Mab) treatment I: suppression of disease activity and acute phase response. Arthritis Rheum. 9:1996;S1300.
9. Levy R., Weisman M., Wiesenhutter C., Yocum D., Schnitzer T., Goldman A., Schiff M., Breedveld F., Solinger A., MacDonald B., Lipani J. Results of a placebo controlled, multicenter trial using a primatized non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis. Arthritis Rheum. 9:1996;S122.
10. Firestein G. S., Zvaifler N. J. How important are T cells in chronic rheumatoid synovitis. Arthritis Rheum. 33:1990;768-773.
11. Kingsley G. H., Pinalis C., Panayi G. S. Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis. J. Rheumatol. 14:1987;667-673.
12. Allen M. E., Young S. P., Michell R. H., Bacon P. A. Altered T lymphocyte signalling in rheumatoid arthritis. Eur. J. Immunol. 25:1995;1547-1554.
13. Maurice M. M., Lankester A. C., Bezemer A. C., Geertsma M. F., Tak P. P., Breedveld F. C., van Lier R. A. W., Verweij C. L. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J. Immunol. 159:1997;2973-2978.
14. Cush J. J., Lipsky P. E. Cellular basis for rheumatoid inflammation. Clin. Orthop. 265:1991;9-22.
15. Firestein G. S., Xu W. D., Townsend K., Broide D., Alvaro-Garcia J. M., Glasebrook A., Zvaifler N. J. Cytokines in chronic inflammatory arthritis. J. Exp. Med. 168:1988;1573-1586.
16. Dolhain R. J. E. M., Ter Haar N. T., Hoefakker S., Tak P. P., De Ley M., Classen E., Breedveld F. C., Miltenburg A. M. M. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br. J. Rheumatol. 35:1996;24-32.
17. Brennan F. M., Field M., Chu C. Q., Feldmann M., Maini R. N. Cytokine expression in rheumatoid arthritis. Br. J. Rheumatol. 30:1991;76-80.
18. Duby A. D., Sinclair A. K., Osborne-Lawrence S. L., Zeldes W., Kan L., Fox D. A. Clonal hetreogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 86:1989;6206-6210.
19. Brennan F. M., Allard S., Londei M., Savill C., Boylston A., Carrel S., Maini R. N., Feldmann M. Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis. Clin. Exp. Immunol. 73:1988;417-423.
20. Tak P. P., Smeets T. J. M., Daha M. R., Kluin P. M., Meijers K. A. E., Brand R., Meinders A. E., Breedveld F. C. Analysis of the synovial cellular infiltrate in early rheumatoid synovial tissue in relation to disease activity. Arthritis Rheum. 40:1997;217-225.
21. Mulherin D., FitzGerald O., Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39:1996;115-124.
22. Zvaifler N. J. Rheumatoid arthritis: The multiple pathways to chronic synovitis. Lab. Invest. 73:1995;307-310.
23. Chu C. Q., Field M., Andrew E., Haskard D., Feldmann M., Maini R. N. Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin. Exp. Immunol. 90:1992;522-529.
24. Marinova-Mutafchieva L., Williams R. O., Mason L. J., Mauri C., Feldmann M., Maini R. N. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107:1997;507-512.
25. Müssener Å., Litton M. J., Lindroos E., Klareskog L. Cytokine production in synovial tissue of mice with collagen-induced arthritis. Clin. Exp. Immunol. 107:1997;485-493.
26. Holoshitz J., Klajman A., Drucker I., Lapidot Z., Yaretzky A., Frenkel A., van Eden W., Cohen I. R. T lymphocytes of rheumatoid arthritis show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet. ii:1986;305-309.
27. Res P. C. M., Schaar C. G., Breedveld F. C., van Eden W., van Embden J. D. A., Cohen I. R., De Vries R. R. P. Synovial fluid T cell reactivity against 65 KD heat shock protein of mycobacteria in early chronic arthritis. Lancet. ii:1988;478-481.
28. Bucht A., Oksenberg J. R., Lindblad S., Gronberg A., Steinman L., Klareskog L. Characterization of T cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. Scan. J. Immunol. 35:1992;159-165.
29. Struyk L., Kurnick J. T., Hawes G. E., van Laar J. M., Schipper R., Oksenberg J. R., Steinman L., De Vries R. R. P., Breedveld F. C., van den Elsen P. J. T cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum. Immunol. 37:1993;237-251.
30. Konttinen Y. T., Bergroth V., Nordström D., Koota K., Skrifvars B., Hagman G., Friman C., Hämäläinen M., Slätis P. Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann. Rheum. Dis. 44:1985;549-555.
31. Breedveld F. C., Dijkmans B. A. C. Differential therapy in early and late stages of rheumatoid arthritis. Curr. Opin. Rheumatol. 8:1996;226-229.
32. Arnett F. C., Edworty S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
33. Parker R. H., Pearson C. M. A simplified synovial biopsy needle. Arthritis Rheum. 6:1963;172-176.
34. Hoefakker S., van't Erve E. H. M., Deen C. Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils. Clin. Exp. Immunol. 93:1993;223-228.
35. Tak P. P., van der Lubbe P. A., Cauli A., Daha M. R., Smeets T. J. M., Kluin P. M., Meinders A. E., Yanni G., Panayi G. S., Breedveld F. C. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum. 38:1995;1457-1465.
36. Tak P. P., Kummer J. A., Hack C. E., Daha M. R., Smeets T. J. M., Erkelens G. W., Meinders A. E., Kluin P. M., Breedveld F. C. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 37:1994;1735-1743.
37. Thurkow E. W., Van der Heijden I. M., Breedveld F. C., Smeets T. J. M., Daha M. R., Kluin P. M., Meinders A. E., Tak P. P. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with yersinia induced arthritis and osteoarthritis. J. Pathol. 181:1997;444-450.
38. Husby G., Williams R. C. Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis Rheum. 28:1985;174-181.
39. Haraoui B., Pelletier J. P., Cloutier J. M., Faure M. P., Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 34:1991;153-163.
40. El-Gabalawy H. S., Keillor J. Immunohistologic study of T cell receptor δ-chain expression in rheumatoid synovial membranes. Sem. Arthr. Rheum. 21:1992;239-245.
41. Lalor P. A., Mapp P. I., Hall P. A., Revell P. A. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki-67. Rheumatol. Int. 7:1987;183-186.
42. Youssef P. P., Kraan M., Bresnihan B., Cassidy N., Cunnane G., Emery P., FitzGerald O., Kane D., Breedveld F. C., Lindblad S., Reece R., Veale D., Tak P. P. Quantitative microscopic analysis of inflammation in rheumatoid synovial membrane samples selected at arthroscopy compared with samples taken blindly by needle biopsy. Arthritis Rheum. 41:1998;663-669.
43. Fava R., Olsen N., Keski-Oja J., Moses H., Pincus T. Active and latent forms of transforming growth factor β activity in synovial effusions. J. Exp. Med. 169:1989;291-296.
44. Katsikis P., Chu C. Q., Brennan F. M., Maini R. N., Feldmann M. Immunoregulatory role of interleukin-10 (IL10) in rheumatoid arthritis. J. Exp. Med. 179:1994;1517-1527.
45. Cope A. P., Liblau R. S., Yang X. D., Congia M., Laudanna C., Schreiber R. D., Probert L., Kollias G., McDevitt H. O. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signalling. J. Exp. Med. 185:1997;1573-1584.
46. Cope A. P., Londei M., Chu N. R., Cohen S. B. A., Elliot M. J., Brennan F. M., Maini R. N., Feldmann M. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J. Clin. Invest. 94:1994;749-760.
47. Maurice M. M., Nakamura H., Van der Voort E. A. M., Van Vliet A. I., Staal F. J. T., Tak P. P., Breedveld F. C., Verweij C. L. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J. Immunol. 158:1997;1458-1465.
48. Tak P. P., Thurkow E. W., Daha M. R., Kluin P. M., Smeets T. J. M., Meinders A. E., Breedveld F. C. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin. Immunol. Immunopathol. 77:1995;236-242.
49. Tak P. P., Smeets T. J. M., Daha M. R., Meijers K. A. E., Brand R., Meiders A. E., Breedveld F. C. Is one year early, or too late. Arthritis Rheum. 40:1997;1913-1914.